Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer

NCT05482451 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Effect of Drug

Interventions

DRUG: Nivolumab
DRUG: all trans retinoic acid

Sponsor

China Medical University Hospital